Literature DB >> 32429646

In vivo and in vitro Pathogenesis and Virulence Factors of Candida albicans Strains Isolated from Cutaneous Candidiasis.

Golnar Sadeghi1, Seyed Fazllolah Mousavi2, Mina Ebrahimi-Rad3, Esmat Mirabzadeh-Ardekani4, Ali Eslamifar5, Masoomeh Shams-Ghahfarokhi6, Zahra Jahanshiri1, Mehdi Razzaghi-Abyaneh1.   

Abstract

Background: The Candida albicans is one of the most important global opportunistic pathogens, and the incidence of candidiasis has increased over the past few decades. Despite the established role of skin in defense against fungal invasion, little has been documented about the pathogenesis of Candida species when changing from normal flora to pathogens of vaginal and gastrointestinal epithelia. This study was carried out to determine the in vivo and in vitro pathogenesis of clinical C. albicans strains isolated from skin lesions.
Methods: In this study, association of in vivo and in vitro pathogenesis of C. albicans isolates with different evolutionary origins was investigated. Oral and systemic experimental candidiasis was established in BALB/C mice. The expression levels of secreted aspartyl proteinases (SAP1-3 genes), morphological transformation, and biofilm-forming ability of C. albicans were evaluated.
Results: All the strains showed in vitro and in vivo pathogenicity by various extents. The SAP1, SAP2, and SAP3 genes were expressed in 50%, 100%, and 75% of the strains, respectively. The biofilm formation ability was negative in 12% of the strains, while it was considerable in 38% of the strains. Fifty percent of the strains had no phospholipase activity, and no one demonstrated high level of this pathogenesis factor. Relatively all the strains had very low potency to form pseudohyphae.
Conclusion: Our findings demonstrated that Candida albicans strains isolated from cutaneous candidiasis were able to cause oral and systemic infections in mice, so they could be considered as the potential agents of life-threatening nosocomial candidiasis in susceptible populations.

Entities:  

Keywords:  Candida albicans; Experimental candidiasis; Virulence factors; in vivo pathogenicity

Mesh:

Substances:

Year:  2020        PMID: 32429646      PMCID: PMC7392142          DOI: 10.29252/ibj.24.5.319

Source DB:  PubMed          Journal:  Iran Biomed J        ISSN: 1028-852X


  28 in total

1.  Profile of Candida albicans-secreted aspartic proteinase elicited during vaginal infection.

Authors:  Brad N Taylor; Peter Staib; Ayfer Binder; Antje Biesemeier; Miriam Sehnal; Martin Röllinghoff; Joachim Morschhäuser; Klaus Schröppel
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

2.  Differences in exoenzyme production and adherence ability of Candida spp. isolates from catheter, blood and oral cavity.

Authors:  Carolina Rodrigues Costa; Xisto Sena Passos; Lúcia Kioko Hasimoto e Souza; Percilia de Andrade Lucena; Orionalda de Fátima Lisboa Fernandes; Maria do Rosário Rodrigues Silva
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2010 May-Jun       Impact factor: 1.846

Review 3.  Epidemiology of invasive mycoses in North America.

Authors:  Michael A Pfaller; Daniel J Diekema
Journal:  Crit Rev Microbiol       Date:  2010       Impact factor: 7.624

4.  The importance of strain variation in virulence of Candida dubliniensis and Candida albicans: results of a blinded histopathological study of invasive candidiasis.

Authors:  L R Asmundsdóttir; H Erlendsdóttir; B A Agnarsson; M Gottfredsson
Journal:  Clin Microbiol Infect       Date:  2009-06       Impact factor: 8.067

5.  Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients.

Authors:  Melyssa Negri; Margarida Martins; Mariana Henriques; Terezinha I E Svidzinski; Joana Azeredo; Rosário Oliveira
Journal:  Mycopathologia       Date:  2009-10-23       Impact factor: 2.574

6.  Property differences among the four major Candida albicans strain clades.

Authors:  Donna M MacCallum; Luis Castillo; Kerstin Nather; Carol A Munro; Alistair J P Brown; Neil A R Gow; Frank C Odds
Journal:  Eukaryot Cell       Date:  2009-01-16

7.  Dynamics of biofilm formation and the interaction between Candida albicans and methicillin-susceptible (MSSA) and -resistant Staphylococcus aureus (MRSA).

Authors:  Chaiene Evelin Zago; Sónia Silva; Paula Volpato Sanitá; Paula Aboud Barbugli; Carla Maria Improta Dias; Virgínia Barreto Lordello; Carlos Eduardo Vergani
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

Review 8.  Candida albicans pathogenicity mechanisms.

Authors:  François L Mayer; Duncan Wilson; Bernhard Hube
Journal:  Virulence       Date:  2013-01-09       Impact factor: 5.882

9.  In vitro and in vivo activity of a novel antifungal small molecule against Candida infections.

Authors:  Sarah Sze Wah Wong; Richard Yi Tsun Kao; Kwok Yong Yuen; Yu Wang; Dan Yang; Lakshman Perera Samaranayake; Chaminda Jayampath Seneviratne
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

10.  Cutaneous candidiasis in Tehran-Iran: from epidemiology to multilocus sequence types, virulence factors and antifungal susceptibility of etiologic Candida species.

Authors:  Golnar Sadeghi; Mina Ebrahimi-Rad; Masoomeh Shams-Ghahfarokhi; Zahra Jahanshiri; Esmat Mirabzadeh Ardakani; Ali Eslamifar; Seyed Fazlollah Mousavi; Mehdi Razzaghi-Abyaneh
Journal:  Iran J Microbiol       Date:  2019-08
View more
  1 in total

1.  Effect of Carum carvi essential oil on ERG6 gene expression and virulence factors in Candida albicans.

Authors:  Samira Nasiri; Masoomeh Shams Ghahfarokhi; Mehdi Razzaghi Abyaneh
Journal:  Curr Med Mycol       Date:  2020-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.